Oxidized LDL as A Biomarker in Metabolic Syndrome

  • Ali W
  • Kushwaha U
  • Wamique M
  • et al.
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Objective: To study the correlation of lipids and lipoprotein indices with special reference to oxidized LDL in study subjects. Material and Methods: Study comprised of total 124 subjects. 104 symptomatic cases either sex age between 20-80 years were recruited, of which, 10 were type-2 diabetes mellitus(Type-2DM), 63 were with metabolic syndrome (MS), and 31 were type-2 diabetes mellitus with hypertension (Type-2DM+HT). Total 20, age and sex matched normal healthy subjects were recruited and served as control group for the present study. Results: Comparing the mean OxLDL of four groups (Type-2DM, MS, Type-2DM+HT and normal), by one way ANOVA showed significantly (p<0.001) differences among the groups. Further, Bonferroni test showed that the mean OxLDL rose significantly (p<0.001) in cases (Type-2DM, MS and Type-2DM+HT) groups as compared to normal group but no differences were observed among the cases. Conlusion: It is concluded that OxLDL may serves as better predictive biomarker in metabolic syndrome individuals.

Cite

CITATION STYLE

APA

Ali, W., Kushwaha, U. P., Wamique, M., Vishwakarma, P., Tasleem, M., Khan, M., & Kumar, A. (2017). Oxidized LDL as A Biomarker in Metabolic Syndrome. Journal of Diabetes & Metabolism, 08(09). https://doi.org/10.4172/2155-6156.1000764

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free